University of Miami
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Miami sits in the top decile of US sponsors by registered trial count (#46 of 15,742 sponsors by registered trial count).
University of Miami: 721 sponsored US clinical trials, 145 recruiting.
University of Miami sponsors 721 registered US clinical trials on ClinicalTrials.gov, 145 of them currently recruiting, and 430 completed. 79 of these trials are in Phase 3-4 (later-stage) and 134 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 10 trials.
Top-decile sponsor footprint
University of Miami ranks in the top decile of sponsors by registered trial count (#46 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
430 of 515 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (83.5%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
721 total, page 11 of 15
Associations of Cognition, Fitness, and Body Composition Among Ethnic Minority Youth
NCT03342924
Sleep-Disordered Breathing in Chronic SCI
NCT02176928
Flow-synchronized Nasal IMV in Preterm Infants
NCT02085499
Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes
NCT02014740
Vitamin D's Effect on Physical Performance in the Elderly
NCT02066441
Everycell's Effect on DNA Damage, Inflammation, and Stress
NCT02032693
Effect of Electromyographic Biofeedback on Quadriceps Neuromuscular Function in Patients With Quadriceps Inhibition
NCT02095223
Deep Brain Stimulation Effects on Gait and Balance in Patients With Parkinson's Disease
NCT02022735
Exercise to Prevent Depression and Anxiety in Older Hispanics
NCT02371954
Families Affected by Dementia: A Survey of Caregivers
NCT02095327
Caring for the Caregiver Network
NCT03049501
SET-Recovery/Healthy Home
NCT02702193
Skilled Motor Training and tDCS to Improve Leg Function After Spinal Cord Injury
NCT01962675
Cetuximab + Taxotere With Low Dose Fractionated Radiation for Head and Neck Carcinoma
NCT01794845
Evaluation of Non-Ablative Laser for Treatment of Direct Brow Lift Scars
NCT02032641
SEPA III: The Effectiveness Trial
NCT02405481
XM-One Study for Living Donor Program
NCT01679184
Get in the GROOVE!
NCT02187939
Wnt, Notch and Hedgehog Activity in Chemo-Naive Tumors Collected During Staging of Esophageal Cancer Patients
NCT02221245
Airway and Pulmonary Vascular Endothelial Function in Healthy Smokers: Effect of Inhaled Glucocorticosteroid Treatment
NCT02141633
Follow-up Yttrium-90 Internal Pair Production PET/CT vs Brehmsstrahlung Imaging in Patients With Primary/Metastatic Liver Tumors
NCT02202317
Safety of LEAD Radiotherapy Plus Chemoradiation in Patients With Bulky Stage III Non-Small Cell Lung Cancer
NCT01797471
Caprylic Triglyceride for Treatment of Cognitive Impairments in Multiple Sclerosis
NCT01848327
Effect of Roflumilast on Airway Blood Flow as an Expression of Airway Inflammation in COPD
NCT02097992
The Measurement of Intraocular Pressure in Normal Children Under General Anesthesia With and Without Nitrous Oxide and Anesthetic Eye Drops
NCT01925391
Caffeine to Reduce Mechanical Ventilation in Preterm Infants
NCT01751724
Doubleblinded RCT of the Omnilux on Lower Extremity Surgical Wounds Left to Heal by Second Intention
NCT02383056
Phase II Study to Evaluate Fenofibrate Therapy in Patients With Smoldering or Symptomatic Multiple Myeloma
NCT01965834
Volume Guarantee Ventilation in Preterm Infants With Frequent Episodes of Hypoxemia
NCT01727505
A Randomized Trial to Evaluate Ampyra for Gait Impairment in Parkinson's Disease
NCT01491022
Liver Fibrosis in Sickle Cell Disease
NCT02007746
Desensitization Protocol for Deceased Donor List
NCT01642225
Coping With Adolescent Peer Victimization and Reducing Anxious/Depressed Symptoms
NCT02011438
Trial for Shoulder Pathology and Pain in Chronic SCI
NCT03521856
Safety Study of Nelfinavir + Cisplatin + Pelvic Radiation Therapy to Treat Cervical Cancer
NCT01485731
MRI-Guided Lattice Extreme Ablative Dose Radiotherapy For Prostate Cancer
NCT01411319
Epicardial Fat in Coronary Artery Disease
NCT03693261
The Use of Antibiotic Sinonasal Rinse After Sinus Surgery
NCT02218307
Hypofractionated Image-Guided Radiotherapy For Prostate Cancer: The HEIGHT Trial
NCT01411332
Using CHWs and HPV Home Tests to Increase Cervical Cancer Screening in Minority Populations
NCT02121548
Magnesium Sulfate Versus 5% Dextrose With Treatment Resistant Depression
NCT01597167
Real-time Diagnosis of Pseudopolyps During Colonoscopy
NCT01557387
Tear Dynamics After Restasis Treatment in Dry Eye Patients
NCT00706940
Culturally Specific Interventions: African American Smokers
NCT01811758
Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial
NCT01157676
Vytorin in the Treatment of Alopecia Areata
NCT01520077
Metabolic Tumor Volumes in Radiation Treatment of Primary Brain Tumors
NCT02006563
Sleep Disordered Breathing and Its Impact on Neuro-cognitive Performance and Quality of Life in Parkinson Disease
NCT02034357
Analysis of the Incidence of Post-Operative Wound Infections After Spine Surgery
NCT02891486
Tetracaine Versus Lidocaine Gel for Anesthetic Effect and Comfort in Patients Undergoing LASIK
NCT01383200
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 48 |
| Phase 2 | 86 |
| Phase 3 | 18 |
| Phase 4 | 61 |
Therapeutic Areas
What is open in the University of Miami pipeline
145 recruiting of 721 indexed (20% open); 430 completed (60%).
Phase mix: 79 late (III/IV) vs 134 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (10 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Miami: open-pipeline peers nationwide
Peers matched on 721 registered trials and 20% open enrollment, not the therapeutic-area sidebar.
University of Miami sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 721 trials (± recruiting share)
- Sanofi · 713 trials · 10% recruiting
- The University of Texas Health Science Center, Houston · 732 trials · 20% recruiting
- Icahn School of Medicine at Mount Sinai · 708 trials · 23% recruiting
- Weill Medical College of Cornell University · 701 trials · 18% recruiting
Sponsors near 20% open enrollment (± trial volume)
- University of California, Irvine · 20% recruiting · 368 trials
- Endeavor Health · 20% recruiting · 94 trials
- Acera Surgical · 20% recruiting · 5 trials
- Align Technology · 20% recruiting · 5 trials
Related
What to do with this University of Miami page
721 registered trials is a research-attention snapshot, not an endorsement of University of Miami or any single study.
- 145 of University of Miami's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition University of Miami studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Miami pipeline card: 721 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.